About this journal
Aims and scope
*Please note that Hypertension in Pregnancy converted to a full Open Access journal from Volume 42 (2023). Previous volumes will continue to provide access through a Pay to Read model.
Hypertension in Pregnancy is a refereed journal in the English language which publishes data pertaining to human and animal hypertension during gestation. Contributions concerning physiology of circulatory control, pathophysiology, methodology, therapy or any other material relevant to the relationship between elevated blood pressure and pregnancy are acceptable. Published material includes original articles, clinical trials, solicited and unsolicited reviews, editorials, letters, and other material deemed pertinent by the editors.
p>Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.Journal metrics
Usage
- 55K annual downloads/views
Citation metrics
- 1.5 (2023) Impact Factor
- 2.1 (2023) 5 year IF
- 3.4 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.474 (2023) SNIP
- 0.442 (2023) SJR
Speed/acceptance
- 16 days avg. from submission to first decision
- 54 days avg. from submission to first post-review decision
- 32% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor
Lana McClements, University of Technology Sydney, Sydney, Australia
Statistics Editor
Natasa M. Milic, Institute for Medical Statistics and Informatics, University of Belgrade, Serbia
Associate Editors
Stefan Hanson, Lund University, Lund, Sweden
Babbette LaMarca, University of Mississippi Medical Center, Mississippi, USA
Ai-Hua Liao, Huazhong University of Science and Technology, China
Dr Renuka Shanmugalingam - Department of Renal Medicine, Liverpool Hospital, NSW, Australia; Western Sydney University, NSW, Australia; SWS Clinical School, University of New South Wales, NSW, Australia
Sonja Suvakov, Mayo Clinic, Rochester, USA
Editorial Board
Dr Bhavisha Bakrania, University of Queensland, Australia
Mathias Fasshauer, University of Leipzig, Germany
Annemarie Hennessy, University of Western Sydney, Penrith, Australia
Wolfgang Holzgreve, Institute of Advanced Study, Germany
Ananth Karumanchi, Harvard Medical School, Boston, USA
Dr Natasa Orlic, Ob/Gyn Clinic Narodni front, School of Medicine, University of Belgrade, Serbia
Holger Stepan, University of Leipzig, Germany
Ravi Thadhani, Harvard Medical School, Boston, USA
Abstracting and indexing
• CABI
• EBSCOhost
• BIOBASE
• Directory of Open Access Journals (DOAJ)
• EMBASE
• Scopus
• MetaPress
• National Library of Medicine; PubMed/MEDLINE
• OCLC
• Personal Alert (E-mail)
• Thomson Reuters; Current Contents, Science Citation Index Expanded, Web of Science
Open access
Hypertension in Pregnancy is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
Continuous publication
Currently known as:
- Hypertension in Pregnancy (1993 - current)
Formerly known as
- Clinical and Experimental Hypertension. Part B: Hypertension in Pregnancy (1982 - 1992)
Formerly part of
- Clinical and Experimental Hypertension (1978 - 1981)
14th World Congress International Society for the Study of Hypertension in Pregnancy abstracts
19th JSSTP Scientific Program abstracts
International Society for the Study of Hypertension in Pregnancy held its 7th World Congress
International Symposium on the Pathophysiology of Hypertension in Pregnancy
International Society for the Study of Hypertension in Pregnancy 1988 WORLD CONGRESS
International society for study of Hypertension in Pregnancy 1986 World Congress
3rd Congress of the International Society for the Study of Hypertension in Pregnancy
Advertising information
Would you like to advertise in Hypertension in Pregnancy?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Hypertension in Pregnancy.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors